biote Corp. SEC filings BTMD
biote Corp. has 411 filings in SEC EDGAR's recent list, going back to Aug 6, 2020. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 2, 2026 | — |
| DEF 14A | Proxy statement | Apr 2, 2026 | May 12, 2026 |
| DEFA14A | Additional proxy material | Apr 3, 2025 | — |
| DEF 14A | Proxy statement | Apr 3, 2025 | May 13, 2025 |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEF 14A | Proxy statement | Apr 11, 2024 | May 21, 2024 |
| DEF 14A | Proxy statement | Apr 14, 2023 | May 17, 2023 |
| DEFA14A | Additional proxy material | May 20, 2022 | — |
| DEFA14A | Additional proxy material | May 17, 2022 | — |
| DEFA14A | Additional proxy material | May 11, 2022 | — |
| DEFM14A | Filing | May 5, 2022 | — |
| DEFA14A | Additional proxy material | Mar 30, 2022 | — |
| PREM14A | Filing | Feb 11, 2022 | Feb 11, 2022 |
| DEFA14A | Additional proxy material | Jan 13, 2022 | — |
| DEFA14A | Additional proxy material | Dec 14, 2021 | — |
| DEFA14A | Additional proxy material | Dec 14, 2021 | — |
| DEFA14A | Additional proxy material | Dec 13, 2021 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- BTMD (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Irving, TX
- SEC filer status
- Accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1819253
- Former names
- Haymaker Acquisition Corp. III (until May 25, 2022)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.